AU2001277824A1 - Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation - Google Patents

Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation

Info

Publication number
AU2001277824A1
AU2001277824A1 AU2001277824A AU7782401A AU2001277824A1 AU 2001277824 A1 AU2001277824 A1 AU 2001277824A1 AU 2001277824 A AU2001277824 A AU 2001277824A AU 7782401 A AU7782401 A AU 7782401A AU 2001277824 A1 AU2001277824 A1 AU 2001277824A1
Authority
AU
Australia
Prior art keywords
preparation
immunomoduling
anticancerogenic
antibacterial
antioxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277824A
Inventor
Anna Vladimirovna Boyko
Valery Ivanovich Chissov
Elena Romanovna Nemtsova
Nadezhda Anatolievna Osipova
Tatyana Vladimirovna Sergeeva
Raisa Ivanovna Yakubovskaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001277824A1 publication Critical patent/AU2001277824A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001277824A 2000-07-13 2001-07-09 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation Abandoned AU2001277824A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2000118424/14A RU2165769C1 (en) 2000-07-13 2000-07-13 Antibacterial, antioxidant, immunomodulating and anticancer preparation and method of its embodiment
RU2000118424 2000-07-13
PCT/RU2001/000276 WO2002003910A2 (en) 2000-07-13 2001-07-09 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation

Publications (1)

Publication Number Publication Date
AU2001277824A1 true AU2001277824A1 (en) 2002-01-21

Family

ID=20237690

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277824A Abandoned AU2001277824A1 (en) 2000-07-13 2001-07-09 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation

Country Status (3)

Country Link
AU (1) AU2001277824A1 (en)
RU (1) RU2165769C1 (en)
WO (1) WO2002003910A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399570B1 (en) 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
CN100467060C (en) 2002-05-10 2009-03-11 阿根尼克斯有限公司 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
SI1545587T1 (en) 2002-09-16 2011-06-30 Agennix Inc Lactoferrin compositions and methods of diabetic ulcer treatment
AU2003296447A1 (en) 2002-12-10 2004-06-30 Agennix Incorporated Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
AU2003293500A1 (en) 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
US7034126B2 (en) 2003-05-14 2006-04-25 Agennix, Inc. Lactoferrin in the treatment of diabetes mellitus
JP2007524654A (en) 2003-06-06 2007-08-30 エイジェニックス インコーポレイテッド Lactoferrin as an adjuvant in cancer vaccines
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
HUE033501T2 (en) * 2010-11-26 2017-12-28 Evonik Roehm Gmbh Human lactoferrin derived peptide for use as an antigen masking agent
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
RU2488406C1 (en) * 2012-02-16 2013-07-27 Общество с ограниченной ответственностью "НТфарма" Pharmaceutical composition for therapy of acute toxic conditions
RU2687969C1 (en) * 2018-03-02 2019-05-17 Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук Antimicrobial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0648955A (en) * 1992-07-29 1994-02-22 Morinaga Milk Ind Co Ltd Activator for digestive tract cell
RU2099065C1 (en) * 1994-09-23 1997-12-20 Московский научно-исследовательский онкологический институт им. П.А.Герцена МЗ РФ Preparation and method for treating local complications occurring during conservative antitumoral treatment in oropharyngeal zone
RU2088238C1 (en) * 1995-02-28 1997-08-27 Московский научно-исследовательский онкологический институт им.П.А.Герцена Agent for rheumatic arthritis treatment
ES2217532T3 (en) * 1997-01-09 2004-11-01 Morinaga Milk Industry Co., Ltd. TABLETS OF LACTOFERRINA.
EP0979099B1 (en) * 1997-04-10 2005-06-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders

Also Published As

Publication number Publication date
WO2002003910A3 (en) 2002-06-20
RU2165769C1 (en) 2001-04-27
WO2002003910A2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AU2002218909A1 (en) Packet encrypton system and method
AU6397301A (en) Synchronization method
AU2001249337A1 (en) Network dma method
AU2001248279A1 (en) New compounds, their preparation and use
AU2001292055A1 (en) Colour system
AU2001289684A1 (en) Glass-ceramics, process for their preparation and use
AUPQ970300A0 (en) Advanced wireless network
AU2002223690A1 (en) Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate
AU2016701A (en) Secure communications method
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001277824A1 (en) Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2002242996A1 (en) Spiroisoquinoline compounds, methods for their preparation and intermediates
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU4263501A (en) Colour specification
AU2001237530A1 (en) Method
AU2001234616A1 (en) Vaccine composition, process and methods
AU2001266176A1 (en) Methods
AU2002216479A1 (en) Isolation method
AU2000267372A1 (en) Polyoxyethylene-polyoxypropylene vitamin e and process for preparation thereof
AU2001266689A1 (en) 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2001241636A1 (en) Halotherapy method
AU2001288496A1 (en) Receiver, and method